Department of Pulmonary and Critical Care Medicine, Research Unit of Respiratory Disease, Hunan Diagnosis and Treatment Center of Respiratory Disease, the Second Xiangya Hospital, Central South University, Changsha, 410011, China.
Department of Cell Biology, School of Life Sciences, Central South University, Changsha, 410013, China.
Mol Med. 2024 Sep 10;30(1):144. doi: 10.1186/s10020-024-00913-9.
Idiopathic pulmonary fibrosis (IPF) is a special kind of chronic interstitial lung disease with insidious onset. Previous studies have revealed that mutations in ZCCHC8 may lead to IPF. The aim of this study is to explore the ZCCHC8 mutations in Chinese IPF patients.
Here, we enrolled 124 patients with interstitial lung disease from 2017 to 2023 in our hospital. Whole exome sequencing and Sanger sequencing were employed to explore the genetic lesions of these patients.
Among these 124 patients, a novel mutation (NM_017612: c.1228 C > G/p.P410A) of Zinc Finger CCHC-Type Containing 8 (ZCCHC8)was identified in a family with IPF and chronic obstructive lung disease. As a component of the nuclear exosome-targeting complex that regulates the turnover of human telomerase RNA, ZCCHC8 mutations have been reported may lead to IPF in European population and American population. Functional study confirmed that the novel mutation can disrupt the nucleocytoplasmic localization of ZCCHC8, which further decreased the expression of DKC1 and RTEL1, and finally reduced the length of telomere and led to IPF and related disorders.
We may first report the ZCCHC8 mutation in Asian population with IPF. Our study broadens the mutation, phenotype, and population spectrum of ZCCHC8 deficiency.
特发性肺纤维化(IPF)是一种起病隐匿的特殊慢性间质性肺疾病。先前的研究表明,ZCCHC8 基因突变可能导致 IPF。本研究旨在探讨中国 IPF 患者的 ZCCHC8 突变。
我们招募了 2017 年至 2023 年期间我院收治的 124 例间质性肺病患者。采用外显子组测序和 Sanger 测序探索这些患者的遗传病变。
在这 124 名患者中,我们在一个同时患有特发性肺纤维化和慢性阻塞性肺病的家族中发现了 Zinc Finger CCHC-Type Containing 8(ZCCHC8)的一个新突变(NM_017612:c.1228 C>G/p.P410A)。作为核外切体靶向复合物的一个组成部分,该复合物调节人端粒酶 RNA 的周转,已有报道称 ZCCHC8 突变可能导致欧洲人群和美国人群的 IPF。功能研究证实,该新突变可破坏 ZCCHC8 的核质定位,进一步降低 DKC1 和 RTEL1 的表达,最终缩短端粒并导致 IPF 及相关疾病。
我们可能首次报道了亚洲人群中 IPF 的 ZCCHC8 突变。我们的研究拓宽了 ZCCHC8 缺陷的突变、表型和人群谱。